Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
BTAI BioXcel Therapeutics
- 0.412
- +0.002+0.54%
Close Dec 13 16:00 ET
- 0.410
- -0.002-0.53%
Post 20:01 ET
19.92MMarket Cap-0.20P/E (TTM)
0.424High0.398Low249.97KVolume0.398Open0.410Pre Close104.21KTurnover0.62%Turnover RatioLossP/E (Static)48.35MShares4.17052wk High-0.23P/B16.58MFloat Cap0.35552wk Low--Dividend TTM40.23MShs Float71.500Historical High--Div YieldTTM6.17%Amplitude0.355Historical Low0.416Avg Price1Lot Size
About BioXcel Therapeutics Company
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Company Profile
SymbolBTAI
Company NameBioXcel Therapeutics
Listing DateMar 8, 2018
Issue Price11.00
Founded2017
CEODr. Vimal Mehta, PhD
MarketNASDAQ
Employees74
Fiscal Year Ends12-31
Address555 Long Wharf Drive,12th floor
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-475-238-6837
Company Executives
- Name
- Position
- Salary
- Dr. Vimal Mehta, PhD
- Director, Chief Executive Officer and President
- 4.73M
- Javier Rodriguez
- Senior Vice President, Chief Legal Officer and Corporate Secretary
- 1.12M
- Dr. Frank D. Yocca, PhD
- Senior Vice President and Chief Scientific Officer
- --
- Richard I. Steinhart
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Vincent J. O'Neill, M.D.
- Executive Vice President, Chief of Product Development and Chief Medical Officer
- --
- Dr. Peter Mueller,PhD
- Chairman of the Board
- 367.33K
- Michael Miller
- Independent Director
- 332.33K
- Dr. Michal Votruba, M.D.,PhD
- Independent Director
- 307.33K
- Dr. Sandeep Laumas, M.D.
- Independent Director
- 329.83K
- David J. Mack
- Independent Director
- --
- June Bray
- Independent Director
- 327.33K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.